ASP-1012

N/A

Report date: 2023/10/25 17:43:04

Base Information

Drug NameASP-1012
Drug Alias NameVET2-L2ASP-1012ASP1012
ClassificationCell and gene therapy > Gene therapyBiologics > Oncolytic virus
Mechanisms of ActionCell death stimulantsImmunologic cytotoxicityInterleukin-2 stimulants
TargetsInterleukin-2
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesKaliVir Immunotherapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesAstellas Pharma IncKaliVir Immunotherapeutics Inc
Inactive CompaniesAstellas Pharma Global Development Inc
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A